Liver Organoid and Liver‐On‐A‐Chip Platforms for Modeling Alcoholic Liver Disease: A Comparative Review
Advanced Healthcare Materials · 2026-02 · 15 (5)
DOI: 10.1002/adhm.202503273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 23.10.2025. Verfasst von Qiannan Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230032, China. Hauptthemen laut MEDLINE: Organoids, Liver Diseases, Alcoholic, Liver, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 171 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Postgraduate Innovation Research and Practice Program of Anhui Medical University, University Synergy Innovation Program of Anhui Province.
Abstract (Originalsprache)
Alcoholic liver disease (ALD) encompasses a spectrum of progressive liver injuries caused by chronic alcohol consumption, including steatosis, hepatitis, fibrosis, and cirrhosis. The development of physiologically relevant preclinical models remains critical for elucidating the pathogenesis of ALD and evaluating therapeutic strategies. Recent advances in liver organoid and liver‐on‐a‐chip (LOC) technologies offer complementary platforms for modeling distinct aspects of ALD. Organoids recapitulate liver tissue architecture with multicellular composition, enabling the study of chronic pathological processes such as lipid accumulation and early fibrogenesis. Conversely, LOC systems replicate dynamic microenvironments such as fluid flow and oxygen gradients, enabling studies of inflammation and vascular injury. In this review, the first comprehensive comparison of liver organoids and LOC systems specifically in the context of ALD is provided. Emerging liver organoid‐on‐a‐chip (OoC) strategies and their potential to model the full spectrum of ALD pathology are also discussed. Finally, key technical challenges are identified, and future directions are proposed targeting patient‐specific, multiorgan, and high‐throughput platforms to advance ALD‐related research and precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230032, China.
- Department of Electronic Engineering and Information Science, University of Science and Technology of China, Hefei, Anhui, 230027, China.
- Department of Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.
ORCID-Profile: Qiannan Chen, Derun Kong
Förderung
- National Natural Science Foundation of China
- Postgraduate Innovation Research and Practice Program of Anhui Medical University
- University Synergy Innovation Program of Anhui Province
- Hefei Key Generic Technology Development Program
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Chen, Q., Li, C., Ding, W., & Kong, D. (2026). Liver Organoid and Liver‐On‐A‐Chip Platforms for Modeling Alcoholic Liver Disease: A Comparative Review. Advanced Healthcare Materials, 15(5). https://doi.org/10.1002/adhm.202503273
Vancouver
Chen Q, Li C, Ding W, Kong D. Liver Organoid and Liver‐On‐A‐Chip Platforms for Modeling Alcoholic Liver Disease: A Comparative Review. Advanced Healthcare Materials. 2026;15(5). doi:10.1002/adhm.202503273
BibTeX
@article{Chen2026,
author = {Chen, Qiannan and Li, Chengpan and Ding, Weiping and Kong, Derun},
title = {Liver Organoid and Liver‐On‐A‐Chip Platforms for Modeling Alcoholic Liver Disease: A Comparative Review},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {5},
doi = {10.1002/adhm.202503273}
}
EUVIMED